Moreover, the CXCL1 level was greater and more clinically correlated in patients with IPAF than among lung disease control subjects with IIP or COPD, further indicating that the production of this chemokine is not only the consequence of lung injury but is specifically involved in the progression of IPAF. Here, CXCL1 is linked to chronic obstructive pulmonary disease.